About us
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.
For more information, please visit www.thermofisher.com.
Get more with Patheon pharma services
About Thermo Fisher Scientific pharma services
Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing through our Patheon™ brand. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey.
With around 60 locations worldwide, we are committed to providing integrated, end-to-end solutions across all phases of development. Our pharma services include API, biologics, cell therapy, viral vectors, formulation, clinical trials solutions, logistics services, and commercial manufacturing, and packaging. We couple our scientific and technical excellence in these areas with a strategic partnership, to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia.
At Thermo Fisher Scientific, we understand that developing novel therapies and moving them from discovery to patients is a complex, high-risk process. Every customer has different needs, and every newly discovered drug has a unique pathway to reach the market. As a global, full-service CDMO, we help our partners bring innovative molecules and life-changing therapies to market as efficiently and safely as possible.
Our commitment to supplier diversity
Our Supplier Diversity Program provides qualified certified small and diverse businesses with opportunities to become a preferred vendor for Thermo Fisher Scientific. We recognize the importance of valuing the diversity of our employees and all whom we do business with, is an integral element of our corporate culture. We are committed to ensuring that we embed an inclusive culture in all our business practices and actively seek to maximize business opportunities for certified small and diverse businesses. Learn more about Thermo Fisher’s Supplier Diversity Program.
Recognitions and awards
Thermo Fisher Scientific recognition:
Winner of Outsourced Pharma’s 2025 CDMO Leadership Award in Small Molecule Dosage Form – Global
What’s new this year?
Refined award categories: Now aligned with sponsor decision-making by evaluating modalities and capabilities. Top CDMOs are recognized in:
- Biologics
- Cell & Gene Therapy
- Small Molecule API
- Small Molecule Dosage Form
Categories are further divided to honor CDMOs across three regions: Global, North America, and International.
A new scoring system combines Net Promoter Scores (NPS) with a “Top 3 Ranking” from survey respondents. Each CDMO receives a final weighted score (1–10), with only those exceeding a qualification threshold within their modality named as finalists and winners.
Recognitions and awards
At Thermo Fisher Scientific, we're dedicated to serving our customers with the highest standards of quality and innovation. Over the years, we've been privileged to receive numerous awards that underscore our unwavering commitment to excellence across all facets of our operations.
2024 CDMO leadership awards
In 2024, Thermo Fisher Scientific was awarded five leadership awards for our contract development and manufacturing organization (CDMO) services.
2024 winner: Capabilities
Overall, Big Pharma, Small Pharma
2024 winner: Compatibility
Overall, Big Pharma, Small Pharma
2024 winner: Expertise
Small Pharma
2024 winner: Quality
Small Pharma
2024 winner: Reliability
Small Pharma
Assurance of quality
Success in business is based on trust, especially in pharmaceuticals. By putting quality at the core of everything we do, Patheon pharma services has earned the trust of clients around the world—and those companies in turn have secured the trust of patients. Trust has been earned through regulatory compliance, exceptional Right First Time/On-Time performance, and safe and effective products. While our ability to generate time and cost efficiencies has earned us business from every corner of the industry, it is our uncompromising quality that continues to build our client relationships and strategic partnerships. We pursue improvement in every functional area of the business, proactively seek out opportunities to prevent problems before they occur, and continuously examine and refine systems and processes. Our ultimate objective is for the pharmaceutical to be of the highest quality possible when it reaches the patient.
Global environmental, health, and safety
Pharmaceuticals, especially highly potent compounds, require strict adherence to regulations and safety practices. We are committed to the health and safety of our employees and the protection of the environment. We comply with evolving regulations and use progressive modernization to mitigate risk for people and the planet. Our company culture is one of prevention, compliance, and improvement. We identify and adopt industry best practices, not only to promote safety, but also to protect against costly delays. We reinforce these efforts through continuous investments in the latest equipment and processes across our global network. See additional details about our Environmental, Health & Safety program and its goals.
Clients we serve
Emerging pharma and biotech
We understand the unique challenges faced by emerging pharmaceutical and biotech companies, including funding constraints, intense time pressures, and the need to build experience and resources beyond the discovery phase. Every day we help remove the barriers that stand between exciting, new discoveries and the patients who need them. We provide instant access to comprehensive capabilities for drug development, clinical trial logistics, and commercial manufacturing of both large and small molecule drug substances and drug products across a wide range of finished dosage forms, including oral solid dose, sterile injectables, and softgels, as well as cell and gene therapies. We bring formulation and process development expertise to pursue early-phase goals and establish a scientifically sound foundation for success in later stages and beyond. What’s more, we’ve created unique solutions dedicated to helping small companies at every turn on their path to market.
We take pride in being able to meet you not only where you are on the road from drug development to commercialization but also where you are in the world. We have a global network of more than 60 locations across 23 countries, including state-of-the-art development and manufacturing facilities throughout North America, Europe, Asia, and Oceania. Since 2010, we have also maintained a presence in Latin America, where our sites in Argentina, Brazil, Chile, Colombia, Mexico, and Peru provide labeling, secondary packaging, distribution, and logistics services, and we are able to offer Importer of Record (IoR) services. We also have facilities in South Africa, India, and Russia. While our team is truly global, we take pride in our ability to serve you locally. What’s more, our support doesn’t end with our CDMO services. We are backed by the entire Thermo Fisher Scientific network, which enables us to support you with a spectrum of solutions, from lab equipment and instruments, to chemicals and scientific supplies, to enterprise services and digital solutions.
Midsize pharma
Many of our midsize clients are transforming the way pharmaceuticals are developed and commercialized with a new vision for their business model. Patheon pharma services is their means to turn that vision into reality. Many midsize companies can benefit from a virtual model with ready access to world-class facilities, technologies, talent, and quality to build highly customized development and manufacturing solutions. This outsourced model provides the agility to quickly scale up or down in response to market conditions, enabling companies to have a lean infrastructure and to focus on their core strengths in discovery and marketing. This model keeps midsized firms from becoming mired in an overly complex supply chain of multiple specialized vendors. We can offer these companies a strategic partnership with our end-to-end capabilities taking their discovery all the way from the lab bench to the patient bedside.
Large pharma
Capacity. Responsiveness. Reliable quality. Those are just three of the reasons that the world’s top 20 pharmaceutical companies put their trust in our drug development and commercial manufacturing expertise. For more than 40 years, we have helped large pharma to manage the ups and downs of demand, mitigate risk with redundant resources, and take advantage of opportunities in markets around the globe. As a strategic partner to the industry’s leaders, we offer innovative solutions that preserve capital and in- house resources, freeing our clients to focus on what they do best.
Generic pharma (OTC)
As generic opportunities grow increasingly complex, we offer the technical expertise, capacity, and agility to capitalize on opportunities. With state-of- the-art facilities, reliable on-time performance, and industry-leading regulatory compliance, we meet strict timelines and provide a dependable, high-quality supply.